Colossal Biosciences
Latest round
- Series C
Last raised
- Sep 2025
Total raised
- $545M
Investors
- 24
About Colossal Biosciences
Founded in 2021 and based in Austin, US, Colossal Biosciences Inc. is a biotechnology firm focused on advanced genetic engineering aimed at de-extinction efforts of species like the Woolly Mammoth, contributing to biodiversity and ecosystem restoration. The company was founded by Ben Lamm and George Chruch,with Ben Lamm being the CEO. In September 2025. Colossal Biosciences Inc.
Who invested in Colossal Biosciences
24 investors across 5 rounds
See all investors in Colossal Biosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Colossal Biosciences
Who invested in Colossal Biosciences?
Colossal Biosciences has 24 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Colossal Biosciences raised?
Colossal Biosciences has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Colossal Biosciences last raise money?
Colossal Biosciences's most recent round on record is a Series C, in Sep 2025.
What does Colossal Biosciences do?
Founded in 2021 and based in Austin, US, Colossal Biosciences Inc.
Where is Colossal Biosciences headquartered?
Colossal Biosciences is headquartered in Austin, US.
Which VCs invest in companies like Colossal Biosciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Colossal Biosciences's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Colossal Biosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.